148 related articles for article (PubMed ID: 20033262)
21. Alkylation of a human telomere sequence by heterotrimeric chlorambucil PI polyamide conjugates.
Kashiwazaki G; Bando T; Shinohara K; Minoshima M; Kumamoto H; Nishijima S; Sugiyama H
Bioorg Med Chem; 2010 Apr; 18(8):2887-93. PubMed ID: 20350810
[TBL] [Abstract][Full Text] [Related]
22. Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia.
Callea I; Console G; Sculli G; Filangeri M; Messina G; Morabito F
Haematologica; 1998 Aug; 83(8):756-7. PubMed ID: 9793266
[TBL] [Abstract][Full Text] [Related]
23. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
[TBL] [Abstract][Full Text] [Related]
24. Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy.
Kratz F; Beyer U; Roth T; Schütte MT; Unold A; Fiebig HH; Unger C
Arch Pharm (Weinheim); 1998 Feb; 331(2):47-53. PubMed ID: 9525088
[TBL] [Abstract][Full Text] [Related]
25. Thiol-inducible direct fluorescence monitoring of drug release.
Wu J; Huang R; Wang C; Liu W; Wang J; Weng X; Tian T; Zhou X
Org Biomol Chem; 2013 Jan; 11(4):580-5. PubMed ID: 23188057
[TBL] [Abstract][Full Text] [Related]
26. Structure-anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil.
Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
Anticancer Drugs; 2006 Jun; 17(5):511-9. PubMed ID: 16702807
[TBL] [Abstract][Full Text] [Related]
27. A morphological study of the effect of chlorambucil during the S and G2 phases of the cell cycle of synchronized HEp-2 cancer cell populations using computerized morphometry.
Zotos A; Marinos E; Sekeri-Pataryas KE; Sourlingas TG
Micron; 2000 Dec; 31(6):623-9. PubMed ID: 10838023
[TBL] [Abstract][Full Text] [Related]
28. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
[TBL] [Abstract][Full Text] [Related]
29. Chlorambucil-sensitive and -resistant lymphoid cells display different responses to the histone deacetylase inhibitor, sodium butyrate.
Kwa FA; Cole-Sinclair M; Kapuscinski M
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):288-92. PubMed ID: 21075074
[TBL] [Abstract][Full Text] [Related]
30. In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.
Reese MJ; Knapp DW; Anderson KM; Mund JA; Case J; Jones DR; Packer RA
PLoS One; 2018; 13(9):e0203517. PubMed ID: 30192852
[TBL] [Abstract][Full Text] [Related]
31. Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Steroids; 2012 Apr; 77(5):403-12. PubMed ID: 22227028
[TBL] [Abstract][Full Text] [Related]
32. Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.
Zheng X; Li W; Lan Z; Yang X; Li L; Yuan Y; Xia Z; Chen X; Zhang X; Yu Y
J Pharm Pharmacol; 2015 Nov; 67(11):1593-602. PubMed ID: 26245909
[TBL] [Abstract][Full Text] [Related]
33. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
[TBL] [Abstract][Full Text] [Related]
34. Sequence-specific DNA cleavage by dipeptides disubstituted with chlorambucil and 2,6-dimethoxyhydroquinone-3-mercaptoacetic acid.
Minnock A; Lin LS; Morgan J; Crow SD; Waring MJ; Sheh L
Bioconjug Chem; 2001; 12(6):870-82. PubMed ID: 11716676
[TBL] [Abstract][Full Text] [Related]
35. Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate.
Chou CJ; O'Hare T; Lefebvre S; Alvarez D; Tyner JW; Eide CA; Druker BJ; Gottesfeld JM
PLoS One; 2008; 3(10):e3593. PubMed ID: 18974832
[TBL] [Abstract][Full Text] [Related]
36. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.
Bello VE; Aloyz RS; Christodoulopoulos G; Panasci LC
Biochem Pharmacol; 2002 May; 63(9):1585-8. PubMed ID: 12007561
[TBL] [Abstract][Full Text] [Related]
37. Alkylating benzamides with melanoma cytotoxicity.
Wolf M; Bauder-Wüst U; Mohammed A; Schönsiegel F; Mier W; Haberkorn U; Eisenhut M
Melanoma Res; 2004 Oct; 14(5):353-60. PubMed ID: 15457090
[TBL] [Abstract][Full Text] [Related]
38. Novel melphalan and chlorambucil derivatives of 2,2,6,6-tetramethyl-1-piperidinyloxy radicals: synthesis, characterization, and biological evaluation in vitro.
Zhao H; Meng X; Yuan H; Lan M
Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):332-5. PubMed ID: 20190437
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy.
Guaragna A; Chiaviello A; Paolella C; D'Alonzo D; Palumbo G; Palumbo G
Bioconjug Chem; 2012 Jan; 23(1):84-96. PubMed ID: 22121907
[TBL] [Abstract][Full Text] [Related]
40. Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma.
Miot-Noirault E; Legault J; Cachin F; Mounetou E; Degoul F; Gaudreault RC; Moins N; Madelmont JC
Invest New Drugs; 2004 Nov; 22(4):369-78. PubMed ID: 15292707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
